Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients
NCT04022161Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2019
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 2
01
Overview
A Phase 2 trial of nitric oxide in endothelial dysfunction, sponsored by Massachusetts General Hospital. Planned start Jul 2019; status: withdrawn.
02
Drugs
nitric oxide
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT04022161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022161.